04 May 2018 --- Lonza has reported a “positive” start to 2018 led by the businesses along the healthcare continuum. The former Capsugel business, now part of Lonza Pharma & Biotech and Lonza Consumer Health, has shown a strong performance following good progress on business and functional integration, the company reports, without giving any details on financial figures. For the coming months, Lonza has announced plans to expand facilities in the US.
13 Apr 2018 --- CJ CheilJedang is making plans to build a production line, dedicated to the creation of L-Arginine and L-Citrulline at its Jombang plant, in Indonesia, which will start operating in 2019. The company currently produces nucleic acid, MSG, arginine and histidine at the Jombang plant. Meanwhile, the company is also planning to improve the productivity of L-Citrulline at its outpost, Ningbo production plant in China.
09 Apr 2018 --- Novartis has entered into an agreement and plan of merger with AveXis, Inc. to acquire the US-based Nasdaq-listed clinical-stage gene therapy company for US$8.7 billion in cash (US$218 per share). The transaction was unanimously approved by the Boards of both companies. The move comes just days after Novartis agreed to sell its stake in a consumer healthcare joint venture for $13 billion to GlaxoSmithKline.
16 Mar 2018 --- A US$70 million investment in a new nutrition bar manufacturing plant in Ontario, California has been announced by Nellson Nutraceutical (Nellson), a North American formulator and manufacturer of branded and private label nutritional bars and functional powders.
14 Mar 2018 --- 14 March 2018 A newly forged partnership between DuPont Nutrition & Health Microbiome Venture and the Center of Food and Fermentation Technologies (TFTAK) will aid strategic research and development of “next-generation” probiotics. This will mark DuPont Nutrition & Healthy Microbiome Venture’s second partnership in three months.
12 Mar 2018 --- Gelita is offering manufacturers of soft gelatin capsules the opportunity to see first hand the complete spectrum of capsule fill release profiles – including the latest addition to Gelita’s pharmaceutical gelatin portfolio: Gelita EC for enteric performance.
26 Feb 2018 --- A majority of online traders recently surveyed by the European Commission are offering novel foods and food supplements that clearly do not comply with EU regulations. This is according to the results of the first coordinated official controls of Internet marketed foods carried out by 25 EU Member States, Switzerland and Norway. Nearly 1,100 websites were checked for certain products which are non-compliant with EU food legislation. More specifically, the investigation mainly focused on four non-authorized novel foods and food supplements bearing medicinal claims, namely Agmatine (4 aminobutyl) guanidine sulfate, Acacia rigidula, Epimedium grandiflorum and Hoodia gordonii.
21 Feb 2018 --- Swiss multinational, chemicals and biotechnology company, the Lonza Group is planning to expand its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. The company will install a new Harro Hӧfliger Modu-C MS encapsulation unit (Harro unit) at its integrated product development and manufacturing facility in Tampa, Florida, to strengthen production and bring its products to market faster.
15 Feb 2018 --- Natures Crops International and De Wit Speciality Oils have entered into a distribution agreement for Ahiflower oil in the European dietary supplement marketplace. This alliance is thought to add strategic value for both companies through each company’s leading position in manufacturing and marketing nutraceutical products.
06 Feb 2018 --- French microalgae supplier Fermentalg has acquired a portfolio of patents to reinforce its intellectual property and industrial and commercial capabilities in the field of omega 3 production. Fermentalg now owns a portfolio of five patents, some of which have already been issued in several countries, to add to its 21 families of active patents already filed. The company has also acquired a number of microalgae strains to add to its bank of over 2,000 strains which is one of the largest in the world.
31 Jan 2018 --- Naturex has signed a global distribution agreement via its Open Innovation program (Ingenium) with Ames-based Cura for their Koji Minerals line of fermented minerals for the dietary supplement and functional food markets. This year’s launches based on Koji fermentation are a stand-alone iron with optimal bioavailability and slow release effect (results supported by two clinical studies) and a blend of seven minerals (iron, zinc, copper, manganese, selenium, molybdenum, chromium) particularly suitable for the multi minerals segment, Naturex reports.
22 Jan 2018 --- The World Health Organization (WHO) has deemed antibiotic resistance to be one of the three greatest threats to human health today, as bacteria become increasingly resistant and too few treatments are being developed to combat them. The research project DRIVE-AB, a consortium managed by the University of Geneva (UNIGE) and AstraZeneca, has determined that a market entry reward of $1 billion per antibiotic globally could significantly increase the number of new antibiotics coming to the market in the next 30 years.
18 Jan 2018 --- The European Food and Safety Authority (EFSA) has rejected a health claim regarding black tea’s effects on the maintenance of normal endothelium-dependent vasodilation in adults. The application, submitted for authorization of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 by Unilever, pertained to “black tea beverages, either freshly prepared or reconstituted from water extract powders of black tea, characterized by the content of flavanols (expressed as catechins plus theaflavins) of at least 30 mg per 200 ml serving.”
16 Jan 2018 --- Calls for a ban on the sale of energy drinks to under 18s have intensified in the Netherlands. Pediatricians are once again arguing for a ban on the sale of energy drinks to young people under the age of eighteen. The Dutch Society for Pediatrics says it is treating more and more young patients who report with symptoms such as restlessness, fatigue and cardiac arrhythmia. A ban is highly unlikely, however, with the Dutch Ministry of Health responding dismissively to the calls.
15 Jan 2018 --- Bayn Europe AB has signed a joint venture agreement with real estate development company HuaHe International Asset Management Ltd. to introduce sugar reduction to the China market. Both partners have agreed on a cooperation model and mutual commitments for the set-up of the joint venture. Under the agreement, Bayn is to hold 65 percent of equity and HuaHe 35 percent.
15 Jan 2018 --- The European Food Safety Authority (EFSA) has increased safe levels of the food processing contaminant 3-MCPD by two and a half fold, from the 2016 Tolerable Daily Intake (TDI) of 0.8 micrograms per kilogram of body weight to 2.0. The revision comes after EFSA experts used an updated scientific approach to reassess the possible long-term adverse effects of 3-MCPD on the kidney and male fertility.
09 Jan 2018 --- Avena Foods Limited of Regina, Saskatchewan and Best Cooking Pulses, Inc. (BCP) of Portage la Prairie, Manitoba have announced a new partnership, effective January 2018. Avena is a leading supplier of gluten-free oats to the North American market. Since 2008, Avena has been providing its customers and consumers with consistent, superior quality, certified gluten-free oats – guaranteed to be free from wheat, barley, and rye.
19 Dec 2017 --- According to research by the organizers of Vitafoods Europe, many people working in the nutrition industry feel positive about the EU’s new process for the approval of novel foods. However, experts are warning that there could be adverse implications for some companies’ intellectual property portfolios. The new regulations on novel foods, defined as anything without a significant history of consumption in the EU before 15 May 1997, come into force on 1 January 2018. For the first time, the approval system will be centralized, with applications submitted to the European Commission rather than individual member states.
13 Dec 2017 --- Frutarom has acquired AB-Fortis activities, including a patent-protected micro-encapsulation technology that enables delivery of iron with increased biological absorption. Frutarom announced the signing of an agreement with AB-Biotics S.A. of Spain for the acquisition of the activity of AB-Fortis in November.
08 Dec 2017 --- Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialized and Westernized, a new study has found. The research – a collaboration between the University of Birmingham, UK, the University of Calgary, Canada, and the Chinese University of Hong Kong – is described by the University of Birmingham as the most definitive and comprehensive study of the global epidemiology of inflammatory bowel disease.